Dalteparin Dosing in High-Flux Haemodialysis and Haemodiafiltration

Publisher： Karger

E-ISSN： 1660-2110|122|1-2|53-57

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.122, Iss.1-2, 2013-03, pp. : 53-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Haemodiafiltration Does Not Reduce the Frequency of Intradialytic Hypotensive Episodes when Compared to Cooled High-Flux Haemodialysis

By  

Nephron Clin Pract, Vol. 119, Iss. 2, 2011-07 ,pp. : c138-c144

Karger

Access to resources Recommend Favorite

Pharmacokinetics of Dalteparin during Haemodialysis

By  

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2013-12 ,pp. : 179-183

Karger

Access to resources Recommend Favorite

Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients

By  

NEPHROLOGY, Vol. 20, Iss. 11, 2015-11 ,pp. : 862-867

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hemoglobin Changes at the Initiation of High-Flux Hemodialysis

By  

Nephron Clin Pract, Vol. 105, Iss. 1, 2006-11 ,pp. : c29-c34

Karger

Access to resources Recommend Favorite

Effect of High Haematocrit on the Efficiency of High-Flux Dialysis Therapies

By  

Nephron Clin Pract, Vol. 110, Iss. 2, 2008-09 ,pp. : c86-c92

Karger

Access to resources Recommend Favorite